Transcend Capital Advisors LLC Boosts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Transcend Capital Advisors LLC boosted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 197.6% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,315 shares of the medical equipment provider’s stock after buying an additional 2,201 shares during the quarter. Transcend Capital Advisors LLC’s holdings in Intuitive Surgical were worth $1,475,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Provence Wealth Management Group purchased a new position in shares of Intuitive Surgical during the 4th quarter worth $276,000. Sequoia Financial Advisors LLC lifted its stake in shares of Intuitive Surgical by 58.0% during the 4th quarter. Sequoia Financial Advisors LLC now owns 8,315 shares of the medical equipment provider’s stock worth $2,805,000 after purchasing an additional 3,054 shares during the period. Public Employees Retirement System of Ohio lifted its stake in shares of Intuitive Surgical by 5.4% during the 4th quarter. Public Employees Retirement System of Ohio now owns 191,283 shares of the medical equipment provider’s stock worth $64,531,000 after purchasing an additional 9,869 shares during the period. HCR Wealth Advisors lifted its stake in shares of Intuitive Surgical by 26.3% during the 4th quarter. HCR Wealth Advisors now owns 1,042 shares of the medical equipment provider’s stock worth $352,000 after purchasing an additional 217 shares during the period. Finally, Kades & Cheifetz LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth $230,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Barclays increased their target price on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. Piper Sandler increased their target price on Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a research report on Friday, July 19th. Morgan Stanley increased their target price on Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a research report on Monday, July 15th. The Goldman Sachs Group assumed coverage on Intuitive Surgical in a research report on Thursday, May 30th. They issued a “buy” rating and a $500.00 target price on the stock. Finally, Robert W. Baird increased their target price on Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a research report on Friday, July 19th. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $442.30.

Intuitive Surgical Price Performance

NASDAQ:ISRG traded down $7.37 during mid-day trading on Monday, reaching $442.36. The stock had a trading volume of 924,720 shares, compared to its average volume of 1,562,410. The company has a market capitalization of $156.91 billion, a price-to-earnings ratio of 81.18, a price-to-earnings-growth ratio of 4.97 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $468.78. The stock’s 50 day simple moving average is $432.13 and its two-hundred day simple moving average is $401.69.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. During the same period last year, the firm earned $1.18 earnings per share. The company’s revenue for the quarter was up 14.5% compared to the same quarter last year. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 239 shares of the firm’s stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $385.55, for a total value of $92,146.45. Following the transaction, the executive vice president now owns 5,507 shares of the company’s stock, valued at $2,123,223.85. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Intuitive Surgical news, insider Gary S. Guthart 7,440 shares of Intuitive Surgical stock in a transaction on Tuesday, July 30th. The was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Robert Desantis sold 239 shares of Intuitive Surgical stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $385.55, for a total value of $92,146.45. Following the sale, the executive vice president now directly owns 5,507 shares in the company, valued at approximately $2,123,223.85. The disclosure for this sale can be found here. Insiders have sold 13,062 shares of company stock valued at $5,589,790 over the last quarter. Insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.